Boston Therapeutics, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Chi-Heng Cheng
IPO Date
2012-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.07
Volume
0.11M
| 1,000,000 |
| $0.10 |
| 10 May 2017 | RAUSCH CARL W | director, officer: CEO | Disposed | 6,000,000 | $0.20 |
| 10 May 2017 | RAUSCH CARL W | director, officer: CEO | Disposed | 1,500,000 | $0.10 |
| 10 May 2017 | RAUSCH CARL W | director, officer: CEO | Disposed | 500,000 | $0.18 |
| 8 Jun 2015 | CONAWAY DALE H | director | P-Purchase | Acquired | 5,000 | $0.12 |
| 18 May 2015 | PLATT DAVID | director, 10 percent owner, officer: CEO and Chairman | P-Purchase | Acquired | 1,000 | $0.15 |
| 18 May 2015 | PLATT DAVID | director, 10 percent owner, officer: CEO and Chairman | P-Purchase | Acquired | 5,000 | $0.12 |
| 20 Mar 2015 | ESBER HENRY JEMIL | director | A-Award | Acquired | 6,000 | $0.37 |
| 20 Mar 2015 | ESBER HENRY JEMIL | director | P-Purchase | Acquired | 9,000 | $0.20 |